GLANVILLE; Jacob
Patent Applications and Registrations
Patent applications and USPTO patent grants for GLANVILLE; Jacob.The latest application filed is for "gpcr binding proteins and synthesis thereof".
- GLANVILLE; Jacob - San Francisco CA
- Glanville; Jacob - South San Francisco CA
| Patent | Date |
|---|---|
| Gpcr Binding Proteins And Synthesis Thereof App 20220281989 - GLANVILLE; Jacob | 2022-09-08 |
| GPCR binding proteins and synthesis thereof Grant 11,407,837 - Glanville August 9, 2 | 2022-08-09 |
| Methods Of Antibody Panning Against Target Proteins App 20220186209 - Glanville; Jacob ; et al. | 2022-06-16 |
| Antigen Binding Molecules And Methods Of Screening Thereof App 20220154171 - GLANVILLE; Jacob ; et al. | 2022-05-19 |
| Optimized Vaccine Compositions And Methods For Making The Same App 20220088175 - GLANVILLE; Jacob ; et al. | 2022-03-24 |
| Method For Mass Humanization Of Non-human Antibodies App 20210380723 - GLANVILLE; Jacob | 2021-12-09 |
| Method for mass humanization of non-human antibodies Grant 11,124,581 - Glanville September 21, 2 | 2021-09-21 |
| Targeted Immunotolerance With A Pd-1 Agonist App 20210206856 - Higginson-Scott; Nathan ; et al. | 2021-07-08 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20210206872 - Pearse; Bradley R. ; et al. | 2021-07-08 |
| Anti-SARS-Cov-2 antibodies derived from 6nb6 Grant 11,053,304 - Glanville , et al. July 6, 2 | 2021-07-06 |
| Anti-SARS-Cov-2 antibodies derived from CR3022 Grant 11,034,762 - Glanville , et al. June 15, 2 | 2021-06-15 |
| Anti-SARS-Cov-2 antibodies derived from 3bgf Grant 11,028,167 - Glanville , et al. June 8, 2 | 2021-06-08 |
| Anti-SARS-CoV-2 antibodies derived from 2DD8 Grant 11,028,150 - Glanville , et al. June 8, 2 | 2021-06-08 |
| Superhuman anti-SARS-CoV-2 antibodies and uses thereof Grant 11,021,532 - Glanville , et al. June 1, 2 | 2021-06-01 |
| Anti-SARS-Cov-2 antibodies derived from 2GHW Grant 11,021,531 - Glanville , et al. June 1, 2 | 2021-06-01 |
| Antibodies And Uses Thereof App 20210147566 - Glanville; Jacob ; et al. | 2021-05-20 |
| Radically Diverse Human Antibody Library App 20210079066 - Glanville; Jacob ; et al. | 2021-03-18 |
| Major Histocompatibility Complex (mhc) Compositions And Methods Of Use Thereof App 20210060126 - Youssef; Sawsan ; et al. | 2021-03-04 |
| Compositions and methods for the depletion of CD117+ cells Grant 10,899,843 - Pearse , et al. January 26, 2 | 2021-01-26 |
| MAdCAM TARGETED IMMUNOTOLERANCE App 20200392228 - Higginson-Scott; Nathan ; et al. | 2020-12-17 |
| Method For Mass Humanization Of Non-human Antibodies App 20190263936 - GLANVILLE; Jacob | 2019-08-29 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20190153114 - Pearse; Bradley R. ; et al. | 2019-05-23 |
| Gpcr Binding Proteins And Synthesis Thereof App 20190135926 - GLANVILLE; Jacob | 2019-05-09 |
| Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing Grant 10,202,640 - Davis , et al. Feb | 2019-02-12 |
| Method for mass humanization of non-human antibodies Grant 10,125,198 - Glanville November 13, 2 | 2018-11-13 |
| Method For Mass Humanization Of Non-human Antibodies App 20170066844 - GLANVILLE; Jacob | 2017-03-09 |
| Single Cell Analysis Of T Cells Using High-throughput Multiplex Amplification And Deep Sequencing App 20150337369 - Davis; Mark M. ; et al. | 2015-11-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 